Form 4: ANI Pharmaceuticals Executive Meredith Cook Reports Stock Transaction
SEC Form 4
Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, reports disposition of shares for tax purposes related to vesting of restricted stock.
Summary
- On July 18, 2024, Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, reported a transaction involving common stock.
- 1,743 shares were disposed of at a price of $61.35.
- The transaction was due to shares withheld for tax purposes related to the vesting of 4,820 shares of restricted stock.
- Following the transaction, Cook beneficially owns 57,238 shares of common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as this is a routine transaction related to tax obligations on vested stock.
Industry Context
This is a routine Form 4 filing, indicating an insider transaction related to stock vesting and tax obligations. Such filings are common and provide transparency into executive stock ownership.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine tax-related stock disposal.
Key Dates
| Date | Description |
|---|---|
| 07/18/2024 | Date of stock transaction and report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.